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leukaemia-like disease, haemic neoplasia, which could be induced, in part, by environmental 11 stressors. The molluscan p53 tumor suppressor gene family was previously shown to be involved in 12 haemic neoplasia at the protein level. The purpose of this study was the quantification of molluscan 13 p53-like isoforms at the mRNA level in mussels with haemic neoplasia compared to normal controls. 14 The three isoforms monitored were a p53-like, a TAp63/73-like containing an intact transactivation 15 (TA) domain, and an NH 2 -terminally truncated p63/73 isoform termed ∆Np63/p73-like that lacks the 16 full TA domain. Using a comprehensive data set of 62 individual M. trossulus and reverse 17 transcription real-time PCR, we found that both the p53 and the ∆Np63/73 isoforms were up-18 regulated in neoplastic haemocytes compared to normal haemocytes (p<0.0001). In contrast, the 19 mRNA levels of the non-truncated isoform TAp63/73 did not change significantly in mussels with 20 the disease at α=0.01 (p=0.0141), in contrast to previous findings at the protein level. Correlations in 21 mRNA levels between the truncated isoform and the full-length isoforms in normal haemocytes were 22 lost in neoplastic haemocytes. The increase in mRNA concentration of the truncated ∆Np63/73 23
Introduction 6
Mussels of the genus Mytilus are distributed widely in boreal and temperate waters of both 7 hemispheres (Gosling, 1992) and have been used for many years in aquaculture and environmental 8 monitoring (Goldberg and Bertine, 2000; Venier et al., 2006) . Mytilus trossulus, among other bivalve 9 species, has a naturally high propensity to develop disseminated or haemic neoplasia (a leukaemia-10 like disease of the haemolymph) (Elston et al., 1992) . Haemic neoplasia is characterized by 11 continuously dividing enlarged malignant haemocytes, which display a high nucleus to cytoplasm 12 ratio and have lost their normal functionality (Mix, 1983 The p53-family proteins have central roles in tumor suppression and embryonic development in 20 vertebrate animals. The family consists of p53 (Lane and Crawford, 1979) , and the more recently 21 discovered homologs p63 and p73 (Kaghad et al., 1997; Yang et al., 1998) . While all family members 22 contain the highly conserved DNA binding domain (DBD), p63 and p73 are characterized by an 23 additional C-terminal region, the sterile alpha motif (SAM), which is implicated in protein-protein 24 interactions in developmental processes (Thanos and Bowie, 1999) . Expression and activity of p53 1 are increased in response to DNA damage, and functional p53 serves as a transcription factor for 2 genes associated with cell cycle arrest and apoptosis, thus preventing the proliferation of aberrant 3 cells (Vogelstein et al., 2000) . p53 mutations have been shown to occur in approximately 50 % of all 4 human cancers (Vousden and Lu, 2002) , and p63 and 73 have been implicated in stem cell identity, 5 neurogenesis, epithelial development, natural immunity and homeostatic control (Kaghad et al., 1997; 6 Yang et al., 1998; Yang et al., 2002) . In some tumor cell lines, p73 is induced in response to DNA 7 damage, mediating a p53-independent cell death pathway (Urist et al., 2004) . 8 9 In invertebrate animals, p53-like proteins have been discovered, such as CEP-1 in the worm 10
Caenorhabditis elegans (Lu and Abrams, 2006) some authors have termed all of the molluscan p53 homologs "p63", with and without a SAM 23 domain, (Goodson et al., 2006 ) based on the finding that molluscan p53 family members are most 24 homologous to vertebrate p63 and the ancestral phylogenetic position of p63 (Yang et al., 2002) . 1 However, the majority of authors have termed the molluscan homologs in accordance with their 2 structural domains consistent with the vertebrate nomenclature, and this nomenclature is also adopted 3 in the current paper. Thus, the p53 isoform was identified and named based on the lack of the SAM 4 haemic neoplasia cells, we wanted to investigate if the same patterns would be observed for 2 transcription of these isoforms. Furthermore, our objective was to test the association between p53-3 isoform gene expression and the haemic neoplasia end point as part of our work to evaluate the use of 4 gene expression in ecosystem monitoring programs. 5
Using isoform-specific quantitative real-time reverse transcription PCR, we analyzed haemocytes 6 from 62 individual M. trossulus animals, which were identified as normal or leukaemic by phase 7 contrast microscopy of the haemolymph. The results show that the p53 and the ∆Np63/73 isoforms 8 are expressed at significantly higher mRNA levels in leukaemic haemocytes when compared with 9 normal haemocytes. This finding provides support for an ancient proliferative role of the ∆Np63/73 10 isoform, and also suggests the potential for p53 as a biomarker for this disease in the context of 11 environmental studies. Adult M. trossulus were collected from continuously submerged cages located in Burrard Inlet, 16
Vancouver, British Columbia. Cages were initially stocked with random samples from a mussel 17 population at Hopkins Landing, Sunshine Coast, B. C., in February of 2006. Mussels were 18 transported to the laboratory and stored in aerated water drawn from the locations and depths of the 19 cages. Mussels were placed in a cold room set to the temperature measured in the field, with frequent 20 seawater changes. Processing of mussel samples was started the same day after sampling and 21 continued, if necessary, the following day. All animals were processed in accordance with the 22
Department of Fisheries and Oceans License Authorizing Fish Collection For Scientific Purposes 23
06.18 and the University of British Columbia Animal Care Protocol A05-0057-R001. 24 1
Haemolymph was withdrawn from the posterior adductor mussel using a pre-chilled 3 ml, 21G-2 syringe and screened by phase contrast microscopy for contamination by gametes or bacteria and 3 particulates, and presence/absence of haemic neoplasia. Absence of haemic neoplasia was defined by 4 the occurrence of only normal haemocytes (approximately 10 6 cells per ml), which were 5 predominately granular and adhesive with pseudopodia ( Figure 1A ). Presence of haemic neoplasia 6 was defined by high cell proliferation (approximately 10 8 cells per ml) and 100 percent round non-7 adhesive cells with no or very few and short pseudopodia ( Figure 1B Phase-contrast micrographs were obtained using a Zeiss Axioplan 2 epifluorescent microscope fitted 12 with a DVC CCD color video camera. Images were captured by Northern Eclipse 6.0 (Empix,  13 Mississauga, ON, Canada) software. were subjected to melt curve analysis, and selected samples were electrophoresed to verify that only 23 one product was present. Amplicons from one sample were sequenced to confirm amplification of the 24 correct isoform sequence. Control reactions were performed with no cDNA template or with non-1 reverse transcribed RNA to determine the level of background DNA contamination after DNaseI 2 treatment. No DNA contamination was detected. The reactions were performed in 96-well plates, 3 each plate containing a standard dilution series. A 1:1 mix of two randomly selected control samples 4 (one leukaemic, one normal) were used to develop a standard curve for all primer sets thus ensuring 5 that the amplification efficiencies were similar between standard and samples. The standard was 6 diluted in five fold increments, and all results were expressed relative to these standard curves. The 7 relative standard deviation of the threshold values (Ct) between triplicates was less than 1%. Data 8 analysis was carried out using the ABI Prism 7000 SDS Software Version 1.0. Threshold and 9
baseline were set to 0.25 and cycles 6 to 15, respectively, for all plates. The efficiency (E) of 10 amplification was determined from the slope of the standard curves according to the following 11 formula: 12 − = slope E 1 10 (1) 13
An efficiency of E = 2 represents 100 % efficiency, i.e. a doubling of PCR product with every PCR 14 cycle. 15
Statistical Analysis 16
All statistical analysis were conducted using JMP IN 5.1 (SAS Institute Inc., Cary, NC). All data sets 17 were tested for normality using the Shapiro-Wilk test and, except for p53 data, were found to be non-18 normally distributed. The non-parametric Wilcoxon rank sum test was used to compare the means of 19 leukaemic with the means of normal sample groups for each isoform (with alpha = 0.01). To test for 20 potential correlations between the transcription levels of the three isoforms in mussels belonging to 21 either the normal or leukaemic population, the Spearman rank correlation test was used. p-values < 22 0.01 were declared significant. 23 24 3. Results 1
Method validation 2
A total of 63 mussel haemolymph samples were analyzed, of which 27 were normal ( Figure 1A ) and 3 36 were end-stage leukaemic ( Figure 1B ) according to phase contrast microscopy observations. All 4 mussel samples were confirmed to be M. trossulus (data not shown). Total RNA extractions yielded a 5 single non-degraded ribosomal RNA band with a size characteristic of 18S rRNA ( Figure 3A ). This is 6 in agreement with previous findings on other mollusks and invertebrates (Ishikawa, 1973 Figures 3C and D) . The average efficiency was 2.09 with 1 standard deviation of 0.132 and efficiencies did not differ significantly between isoforms. 2 3.2. Isoform mRNA levels in normal and leukaemic haemocytes 3
Using this comprehensive data set, we analyzed whether any of the three isoforms in the p53 family 4 (p53, TAp63/73, or ∆Np63/73), were significantly up-or down-regulated at the mRNA level in either 5 the normal or leukaemic haemocyte group. All isoforms were ubiquitously expressed in both 6 leukaemic and normal haemocytes (Figure 4 ). The lowest mRNA levels were found in the ∆Np63/73 7 isoform. Within each haemocyte group, p53 data points were distributed normally, while TAp63/73 8 and ∆ Np63/73 data points were positively skewed. Therefore, Wilcoxon rank sum tests were used for 9 the comparison. Each group contained a small number of outliers (as defined by being outside the 1.5 10 interquartile range) for each isoform, all of which were included in the analysis. The variances were 11 different for the three isoforms, ranging from 0.0022 to 0.0645, and were independent of health 12 status. 13 p53 isoform mRNA levels showed the greatest difference (p<0.0001) between leukaemic and normal 14 haemocytes. The mean mRNA levels were 0.22 (± 0.01 standard error, SE) and 0.07 (± 0.01 SE) for 15 leukaemic and normal haemocytes, respectively (Figure 4 ). The ∆Np63/73 isoform also showed a 16 significant difference (p<0.0001) in mRNA levels, with a mean of 0.09 (± 0.01 SE) and 0.03 (± 0.02 17 SE) for leukaemic and normal haemocytes, respectively. In contrast to the other two isoforms, mRNA 18 levels of the TAp63/73 isoform did not change between leukaemic and normal mussels at the 19 predetermined α of 0.01 (with p=0.0141), with respective group means of 0.14 (± 0.04 SE) and 0.23 20 (± 0.05 SE) ( Figure 4 ). The range of distribution of TAp63/73 data points is larger than the range of 21 p53 or ∆Np63/73 data points. 22
Relationships between isoforms 23
The balance in transcription of the p53 family members plays an important role in the development of 1 tumors and the normal cell cycle. To determine potential alterations in transcriptional control between 2 the isoforms we analyzed the correlation among isoforms in leukaemic and normal samples ( Table 1) . 3
The strongest correlation was detected between ∆Np63/73 and p53 in normal haemocytes (r=0.63, 4 p=0.0008), and a somewhat weaker correlation between ∆Np63/73 and TAp63/73 (r=0.51, 5
p=0.0085). These correlations did not persist in leukaemic haemocytes. 6 Our results strongly suggest the involvement of p53 and ∆Np63/73 mRNA in haemic neoplasia in M. 10 trossulus, since both of these isoforms are expressed at significantly higher levels in the neoplastic 11 versus normal cells (p<0.0001). This up-regulation is not reflected in the TAp63/73 isoform, which 12 was transcribed at levels similar to or lower than the average for most of the leukaemic haemocytes, 13 with a wide dispersal of data points. This may be the result of differences in regulation pathways 14 between the p53 and ∆Np63/73 isoforms and the TAp63/73 isoform. The increase in mRNA levels of 15 the p53 isoform in leukaemic haemocytes may be counteracted by genetic changes that inhibit the 16 activity of the tumor suppressor, as it was shown for example for Burkitt's lymphoma (Balint and 17 Reisman, 1996) . 18
While leukaemic haemocytes are a homogenous cell type, normal haemocytes are heterogeneous and 19 can be divided morphologically into granular and agranular cells (Cheng, 1981), as well as into 20 eosinophilic and basophilic cells (Pipe et al., 1997) . We therefore expected to observe a higher 21 variability in transcription data in the normal groups. Surprisingly, this was only the case for 22
ΤΑp63/73, but not for p53 or ∆N p63/73. We tested for potential correlations between the 23 transcription levels of the three isoforms in mussels belonging to either the normal or leukaemic 24 group. The ∆Np63/73 isoform data show a much higher correlation to p53 and TAp63/73 data in the 1 normal than in the leukaemic group (Table 1 ). The correlations found in normal haemocytes appear to 2 be lost in leukaemic haemocytes and therefore the balance that exists between the oncogenic 3 ∆Np63/73 and tumor-suppressing p53 and TAp63/73 isoforms may be disturbed in haemic neoplasia. 4
Pathways that potentially link these isoforms to each other may also be impaired. Similar 5 deregulation of p53 isoform expression has been shown in many human cancers (reviewed in 6 (Bourdon, 2007) and it is hypothesized that wild-type p53 activity may be modulated by the presence 7 of other p53 isoforms. 8
Because it is likely that only one p53 gene is present in molluscs, it is conceivable that there are more 9 than the three currently known isoforms expressed from the Mytilus p53 gene. Based on the 10 placement of the real-time PCR primers (Figure 2) , the transcription data we provide here may 11 include transcription of more than one isoform per primer set. For instance, the ∆Np63/73 primer set 12 may have detected the known ∆ Np63/73 as well as a potential ∆Np53. This has to be kept in mind 13 when interpreting the data and will also affect the validity of the comparison between mRNA and 14 protein levels (see 4.2.). 15 Mytilus leukaemic haemocytes by other authors may be correlated with the increase in ∆Np63/73 11 mRNA but not with TAp63/73 mRNA levels observed here, but until the actual identity of the 12 proteins detected by the antibodies can be confirmed, this hypothesis cannot be substantiated. Clearly, 13 a more specific and coherent set of antibodies is required to clarify the relationships between mRNA 14 and protein in the molluscan p53 family. 15 16 
Comparison of molluscan mRNA isoform data with data on vertebrate p53/63/73 in tumors 17
Under normal conditions, the mammalian p53 protein is kept at low levels in the cell by its relatively 18 short half-life mediated by proteolytic turn over. Despite the large number of stress signals that input 19 into the p53 pathway, we know almost nothing about how these diverse inputs are communicated to 20 the p53 protein (Levine et al., 2006) . It is likely that the functional, temporal and tissue or tumor-21 specific differences in mammalian p53, p63 and p73 expression are in part due to highly 22 differentiated transcriptional regulation pathways. It has been shown that the expression of the 23 various isoforms for each vertebrate family member is initially regulated at the mRNA transcriptional 24 level in normal as well as tumor tissues (Bourdon et al., 2005) . Molluscan models can offer an 1 advantage over other models for studying the ancient normal and abnormal functions of p53 family 2 members, as they likely contain only one p53-like gene and transcriptional regulation may be simpler. 3
Despite limitations due to the differences in genetic organization between invertebrates and 4 vertebrates, the following comparison between p53 family mRNA transcription in a molluscan cancer 5 and in vertebrate cancers shows a number of analogous patterns: 6
Normal differentiated cells have a low constitutive p53 mRNA transcription which is, in part, 7
regulated at the transcriptional level. 8
Normal molluscan haemocytes are thought to be terminally differentiated cells unable to further 9 divide in primary cell culture. We and others (for instance Elston, 1992) have observed that cell 10 division is drastically increased when these haemocytes undergo neoplastic transformation and we 11 now show that p53 mRNA levels rise in neoplastic haemocytes. Expression of the vertebrate p53 12 gene is under tight transcriptional control during the normal cell cycle (Boggs and Reisman, 2005). 13 p53 mRNA is maintained at low levels during G 0 /G 1 growth arrest and increases with re-entry into 14 the cell cycle. Importantly, this increase in p53 mRNA levels is due to an increase in transcription. 15
For example, protein kinase C has been shown to be required for basal transcription of the vertebrate 16 p53 gene, rather than p53 protein stabilization (Abbas et al., 2004) . Down-regulation of protein 17 kinase C by inhibitors inhibits transcription from the p53 promoter which has been suggested as a 18 mechanism for tumor promotion. However, nothing is known about the pathways in molluscs. 19
p53 mRNA levels are significantly increased in molluscan haemic neoplasia and in some 20
human cancers. 21 The mRNA levels of p53 are significantly increased in Mytilus haemic neoplasia. It has been shown 22
for some human cancers that p53 activity is increased not only because of an increase in the stability 23 of mutated p53, but also by an increase at the mRNA transcription level (Balint and Reisman, 1996) . favoring their proliferation (Mills, 2005) . Similar to ∆Np63, a significant percentage of tumors also 9 specifically select for the dominant negative ∆Np73 isoforms, which strongly argues for their biomarker. Clustering of p53 and ∆Np63/73 data-points improves the diagnostic power that 10 differentiates leukaemic from normal haemocytes (data not shown), and a combination of mRNA 11 expression data rather than individual mRNA data-points should be considered in future studies. The 12 p53 family was shown previously to be down-regulated in mussels exposed to an organic pollutant 13 mix (Dondero et al., 2006) . However, as we know from vertebrate models, different isoforms have 14 different functions and expression profiles and it is therefore important that monitoring tools can 15 distinguish between them. However, a number of questions remain to be answered before p53 can be 16 fully validated as a genetic biomarker of neoplasia. neoplasia. This is in contrast to previous observations at the protein level and requires further 20 investigation. 21 5.5. The balance in mRNA levels that may exist between p53 and ∆Np63/73-like isoforms in normal 22
haemocytes is not maintained in leukaemic haemocytes. 23 5.6. Genetic biomonitoring tools need to take into account different isoforms of gene products as they 1 may have distinct transcription patterns and opposing functions. 
